Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Three molecular subtypes of advanced skin T-cell lymphoma were identified, with potential biomarkers for predicting treatment response and disease progression.

The 14-3-3σ gene is essential for preventing hair loss.

STEAP3 protein might help treat hair loss, but more testing is needed.

Certain patient characteristics can help predict hair regrowth success with ritlecitinib in alopecia areata.

Reduced matriptase activity causes skin and hair issues in both humans and mice.

Activating TRPV3 reduces skin oil production and increases inflammation, potentially causing dry skin issues.

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.

A reliable method was developed to measure Finasteride and Tadalafil in rat blood.

Cancer cells often have more copies of TERT and TERC genes, which helps them grow and could affect patient outcomes.

Long-term testosterone treatment helps men with low testosterone levels lose weight.

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

Tirzepatide may improve hair loss by reducing insulin resistance.

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.

Ritlecitinib 50 mg effectively promotes and sustains hair regrowth in alopecia areata patients.

A new treatment using a special gel with miR-665 reduces inflammation and helps hair regrow in alopecia areata.

The FDA approved a new Pfizer drug for hair loss in teens.

Two new mutations in the CDH3 gene cause hair loss and vision problems in a young girl.

Scientists found new, better-working inhibitors for a hormone-related enzyme.

The combination therapy was effective and well-tolerated, especially in young patients.

A genetic mutation in the CDH3 gene causes hair loss and vision problems in a young Saudi girl.

The DMI3 gene is essential for nodule development and symbiosis in certain plants.

The document's conclusion cannot be provided because the document is not accessible.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

The human type II 5α-reductase gene, linked to certain male health conditions, has a specific structure and low similarity to other related genes.

DHT enhances androgen receptor activity more than testosterone, and MAGE-11 influences this activity through specific interactions.